EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Prevalence of Vitamin D Deficiency and Its Association with Disease Activity among Libyan Patients with Inflammatory Bowel Disease

Omaima Ben Krayem

Attahadi Medical Journal · 2026

DOI: 10.69667/amj.26327 ↗
AbstractBibliografische Angaben

Abstract

Vitamin D deficiency is a recognized non-skeletal concern in patients with inflammatory bowel disease (IBD) due to its immunomodulatory roles. However, regional data on vitamin D status in North African IBD cohorts, particularly in Libya, remain scarce. This study aimed to evaluate the prevalence of low serum 25-hydroxyvitamin D (25(OH)D) levels in Libyan IBD patients and examined its association with disease activity state. A cross-sectional study was conducted involving 71 adult IBD patients and 20 age-, sex-, and BMI-matched healthy controls. Demographic, clinical, and laboratory data, including serum 25(OH)D, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR), were collected. Disease activity (active flare vs. clinical remission) was evaluated using a composite assessment of clinical symptoms, medical records, laboratory biomarkers, and endoscopic findings. Statistical comparisons were performed using Mann-Whitney and Fisher’s exact tests. The IBD cohort had a mean age of 36.35 ± 15.78 years and a mean BMI of 25.51±4.54 kg/m2. Results revealed a high prevalence of vitamin D deficiency among the IBD cohort, where 86% of patients presented with suboptimal vitamin D levels (serum 25(OH)D < 30 ng/ml) and exhibited substantially lower levels (mean 20.32 ng/ml) compared to controls (mean 31.20 ng/ml) (p < 0.0001). A statistically significant association between active disease state and lower vitamin D levels compared to remission periods (median 16.90 ng/mL vs 21.50 ng/mL, p < 0.05) with patients presenting with active disease having nearly six-fold increased odds of vitamin D deficiency than those in remission. In conclusion, suboptimal vitamin D status is highly prevalent among IBD patients in Misurata, Libya, with disease activity acting as the primary driver of vitamin D depletion regardless of patient gender, underscoring the critical need for continuous assessment and the implementation of effective supplementation strategies to improve therapeutic outcomes across all IBD cohorts.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →